HLIT vs ITRN

HLIT exhibits a stable but mediocre Piotroski F-Score of 4/9, while deterministic value metrics (Graham Number $0.88, Intrinsic Value $0.07) suggest the stock is severely overvalued at its current price of $9.75. The company is facing a catastrophic collapse in growth, with YoY revenue down 55.8% and Q/Q revenue down 123.87%. While the balance sheet remains healthy with a low Debt/Equity ratio of 0.35 and a strong Current Ratio of 2.50, the fundamental disconnect between price and performance is extreme. The market appears to be pricing in a recovery based on a Forward P/E of 13.43, but current data shows a trailing P/E of 975 and negative profit margins.

ITRN exhibits exceptional financial health with a Piotroski F-Score of 8/9, indicating strong operational efficiency and balance sheet strength. While the current price of $53.54 is a significant premium over the Graham Number ($26.84), it remains well below the growth-based intrinsic value of $67.31. The company combines steady double-digit growth with a highly attractive 11.21% dividend yield and negligible debt (D/E 0.02). Despite a bearish technical trend score and weak insider sentiment, the fundamental data suggests a high-quality compounder with significant margin of safety in its health metrics.